Atlas Trials

Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy With Reduced Ejection Fraction: ANSWER-HF.

Clinical trial NCT04853758 · UNKNOWN

Trial details

NCT number
NCT04853758
Sponsor
University of Sao Paulo General Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Chagas Cardiomyopathy
Start date
2021-05-06
Primary completion
2024-12-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.